CYNTHIA WHEELER: Open Payments
NPI 1265721419 · NASHVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,145 in 52 payments from 9 companies in 2025. Trend: 2023 $815 · 2024 $849 · 2025 $1,145
Food & beverage: $1,145
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $254 |
| Gilead Sciences, Inc. | 14 | $251 |
| Ipsen Biopharmaceuticals, Inc | 9 | $214 |
| Madrigal Pharmaceuticals | 8 | $199 |
| Intercept Pharmaceuticals, Inc. | 4 | $95 |
| ORPHALAN INC | 2 | $53 |
| Mirum Pharmaceuticals, Inc. | 2 | $38 |
| Eton Pharmaceuticals, Inc. | 1 | $23 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $19 |
Products named: MAVYRET, IQIRVO, REZDIFFRA, OCALIVA, CUVRIOR, Livmarli, GALZIN, XIFAXAN.
Industry payments across TN — which companies pay providers there.
